IHT Wealth Management, LLC - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 414 filers reported holding CRISPR THERAPEUTICS AG in Q4 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.3%.

Quarter-by-quarter ownership
IHT Wealth Management, LLC ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$343,604
-23.2%
7,570
-5.0%
0.02%
-26.1%
Q2 2023$447,437
+20.9%
7,970
-2.6%
0.02%
+9.5%
Q1 2023$370,026
-9.9%
8,181
-19.0%
0.02%
-19.2%
Q4 2022$410,565
-37.4%
10,100
+0.5%
0.03%
-48.0%
Q3 2022$656,000
+46.4%
10,045
+36.2%
0.05%
+28.2%
Q2 2022$448,000
-3.4%
7,377
-0.1%
0.04%
+11.4%
Q1 2022$464,000
-17.1%
7,3850.0%0.04%
-14.6%
Q4 2021$560,000
-23.6%
7,385
+12.7%
0.04%
-31.7%
Q3 2021$733,000
-51.3%
6,550
-29.6%
0.06%
-37.5%
Q2 2021$1,506,000
+43.7%
9,300
+8.1%
0.10%
+28.0%
Q1 2021$1,048,000
-27.3%
8,600
-8.7%
0.08%
-37.5%
Q4 2020$1,442,000
+120.8%
9,416
+20.6%
0.12%
+81.8%
Q3 2020$653,000
+102.8%
7,807
+78.3%
0.07%
+50.0%
Q2 2020$322,000
+26.8%
4,379
-18.7%
0.04%
+18.9%
Q2 2019$254,000
+13.4%
5,383
+6.6%
0.04%
-22.9%
Q3 2018$224,000
-24.6%
5,0510.0%0.05%
-36.8%
Q2 2018$297,000
+23.8%
5,051
-9.0%
0.08%
+18.8%
Q1 2018$240,000
+67.8%
5,551
+0.9%
0.06%
+68.4%
Q4 2017$143,000
+32.4%
5,5010.0%0.04%
-17.4%
Q3 2017$108,000
+440.0%
5,501
-2.2%
0.05%
+360.0%
Q2 2017$20,000
-81.8%
5,627
+1.4%
0.01%
-86.3%
Q1 2017$110,0005,5470.07%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q4 2020
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$27,989,04633.20%
Gilfoyle Management LLC 100$4,84215.90%
NEA Management Company, LLC 1,587,854$89,142,1246.80%
ARK Investment Management 7,338,447$411,980,3942.73%
Nikko Asset Management Americas, Inc. 3,533,357$198,327,3282.09%
Del-Sette Capital Management, LLC 33,661$1,889,7291.79%
Ikarian Capital, LLC 200,000$11,228,0001.79%
Ikarian Capital, LLC 200,000$11,228,0001.79%
Merlin Capital, Inc 8,802$494,1441.67%
Green Alpha Advisors, LLC 34,373$1,929,7001.27%
View complete list of CRISPR THERAPEUTICS AG shareholders